Author

T. Stokowy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

A. J. Cortez· 1 shared A. Krzywon· 1 shared A. Toma-Jonik· 1 shared B. Gao· 1 shared B. Gielniewski· 1 shared B. Wojtas· 1 shared D. Bohan· 1 shared D. Micklem· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Cortez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19

D. Bohan, H. Van Ert, N. Ruggio, K. J. Rogers, M. Baddredine, J. A. A. Briseno, R. A. Rojas Chavez, B. Gao, T. Stokowy, E. Christakou, D. Micklem, G. Gausdal, H. Haim, J. Minna, J. B. Lorens, W. Maury

This study identifies PS receptors, including AXL, as facilitators of SARS-CoV-2 infection by enhancing virus entry into human lung cells, suggesting AXL as a therapeutic target for COVID-19.

bioRxiv · Jun 15, 2021Microbiology

Heat Shock Factor 1 (HSF1) as a new tethering factor for ESR1 supporting its action in breast cancer.

N. Vydra, P. Janus, P. Kus, T. Stokowy, K. Mrowiec, A. Toma-Jonik, A. Krzywon, A. J. Cortez, B. Wojtas, B. Gielniewski, R. Jaksik, M. Kimmel, W. Widlak

This study shows HSF1 enhances ESR1's genomic action in breast cancer, increases transcriptome diversity, and together they predict poor prognosis in ER-negative cancers.

bioRxiv · May 6, 2021Cancer Biology

Proteome and phosphoproteome changes associated with prognosis in acute myeloid leukemia

M. d. C. Hernandez-Valladares, E. Aasebo, F. S. Berven, S. Bartaula-Brevik, T. Stokowy, R. Hovland, M. Vaudel, S. O. Doskeland, E. McCormack, T. S. Batth, J. V. Olsen, O. Bruserud, F. Selheim

This study identifies proteome and phosphoproteome changes associated with AML relapse using patient samples and validates them with kinase inhibitors.

bioRxiv · Oct 10, 2019Cancer Biology